摘要
目的:探讨肺泡灌洗与雾化吸入对COPD肺心病伴肺部感染患者肺功能及不良反应的影响。方法:选取2018年2月-2020年2月笔者所在医院收治的60例COPD肺心病伴肺部感染患者为研究对象,根据治疗方法的不同将其分为对照组(n=30)和观察组(n=30)。对照组予以肺泡灌洗,观察组则采用雾化吸入。比较两组临床治疗效果、治疗前后肺功能指标及不良反应发生情况。结果:观察组治疗总有效率为96.67%,高于对照组73.33%,差异有统计学意义(P<0.05)。两组治疗前肺功能指标比较差异无统计学意义(P>0.05);观察组治疗后PEF、FEV1、PVC均高于对照组,差异有统计学意义(P<0.05)。观察组不良反应发生率为6.67%,低于对照组的26.67%,差异有统计学意义(P<0.05)。结论:针对COPD肺心病伴肺部感染患者的临床治疗中,雾化吸入具有较高的应用价值,临床治疗效果较好,有效改善患者肺功能,减少不良反应的发生,值得推广和应用。
Objective:To investigate the effects of alveolar lavage and nebulized inhalation on pulmonary function and adverse reactions of COPD patients with pulmonary heart disease and pulmonary infection.Method:A total of 60 patients with COPD pulmonary heart disease and pulmonary infection admitted in our hospital from February 2018 to February 2020 were selected as the research objects,and they were divided into the control group (n=30) and the observation group (n=30) according to different treatment methods.The control group was treated with alveolar lavage,and the observation group was treated with nebulized inhalation.The clinical effect,pulmonary function indexes before and after treatment and the occurrence of adverse reactions were compared between the two groups.Result:The total effective rate of the observation group was 96.67%,which was higher than 73.33% of the control group,the difference was statistically significant (P<0.05).There was no statistically significant difference in pulmonary function indexes between the two groups before treatment (P>0.05).After treatment,PEF,FEV1 and PVC in the observation group were higher than those in the control group,and the differences were statistically significant (P<0.05).The incidence of adverse reactions in the observation group was 6.67%,which was lower than 26.67% in the control group,and the differences was statistically significant (P<0.05).Conclusion:In the clinical treatment of COPD patients with pulmonary heart disease and pulmonary infection,nebulized inhalation has a high application value,and the clinical treatment effect is good.It can effectively improve the pulmonary function of patients and reduce the occurrence of adverse reactions.It is worthy of promotion and application.
作者
段文华
DUAN Wenhua(Yong’an General Hospital of Sanming City,Yong’an 366000,China)
出处
《中外医学研究》
2021年第25期156-158,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
肺泡灌洗
雾化吸入
COPD肺心病伴肺部感染
肺功能
不良反应
Alveolar lavage
Nebulized inhalation
COPD pulmonary heart disease and pulmonary infection
Pulmonary function
Adverse reactions
